Transcript
Speaker: Welcome to the regulatory executive podcast series where we discuss innovation and digital transformation in the life sciences regulatory space. I'm your host, Steve Gens, founder and managing partner of Gens & Associates.
Speaker: Today is a special guest because, Olivier, you were our first podcast guest in July of two years ago. and Back then, you had a lot of acquisitions and we were talking about that.
Speaker: And after 27 years of running the company, there's another major transition that we're going to start with. But before we get into that, for our listeners, if you could just quickly introduce yourself and Endno, and then we'll get rolling.
Speaker: Yes, so hello, everybody. Thank you, Steve, for inviting me for a second time after close to, yes, a bit more than two years. So I'm Olivier Paris. I'm the founder of Enoch, as well as... uh co for 26 years
Speaker: and ah recently transitioning to a new a new phase of Enov Growth. So for those who don't know Enov, Enov is a software vendor in the life science industry providing a a compliant, unified platform that addresses multiple needs like manual regulatory, quality. clinical, pharmacobigilance, and also commercial.
Speaker: So that start there, you are actually have just started a new phase with a significant investment. growth investment by, I believe it's Bruegel, Segmont, and Ardian, if I'm pronouncing that right.
Speaker: But the question on this is, you know, what drove this and and why now? So I'm just really kind of curious and I'm sure our listeners are too. Yeah, so... Well. Why now is, um I would say...
Speaker: maybe i agree to start with this for more than 20 years i would say almost every year i'm Stole by the mice. former CFO and many people that. I should bring in investors to accelerate the growth of Enov.
Speaker: And I would say that. tier recently i haven't been much open to that because wow I had a lot of things going on. You know that when we did this podcast two years ago, we well we completed a few acquisitions from 2022 to 2024. One acquisition in 2022, another one in 2023, two in 2024 with a major one, which is the...
Speaker: calyx slash ah insight acquisition And well, I thought it was the right time for the company ah reaching this level of revenue, number of employees, and also the customers we we have using our solution. It was the right time to bring in investors.
Speaker: because it was also a request of some customers to to say that. Being backed by... ah Private equity or making sure that there is a possibility to accelerate the growth is also securing their investment in into NO.
Speaker: And also one one thing which is very important to me is, or was and still is, is to accelerate our growth of and on the North American market. So that's why we started discussions with investors.
Speaker: mainly US investors. So something we started in 2025. And that brought us to, I would say... investment of two private equities, Segment, Bregal Segment, a U .S. base who who is the lead investor. And Ardian, who is a minority one, but who is the largest French private capital player and a part of the top 10. global players. So it was... key for me to have
Speaker: US investor to help us grow there. as well as a more local one to to our DNA because since we are initially a French company.
Speaker: and to also sustain our growth in Europe. So, that's so. Why? We thought it was the right time. and also the right people to. help us on the second phase of our journey.
Speaker: Yeah, and it's an interesting time, too. um Last year, we started speaking about the convergence of change in broader life sciences, but specifically. in regulatory and that indeed it's the start of the new era and it's a lot more than just AI. There's ways of working, cloud -based regulatory spaces.
Speaker: A lot of exciting things. And I would imagine, too, that it's also timely, not only for your goals of you know global expansion and acceleration.
Speaker: But how do you embrace and maximize this new era that we're coming into? It's it's truly some exciting times. i mean I've been around life sciences probably as long as you, you know.
Speaker: And there's always change that's going on, but you know in the last 18 months, it's pretty significant and it's going to be picking up. even more, so truly interesting times. yeah The next thing I wanted to touch on, and it's kind of an interesting question because we're both founders. now you're a You're a few years ahead of me. I've i've only had the company for 22 years. I think you said 26 or 27.
Speaker: you know But it's kind of ah a unique situation when you build a company. it's successful, bring on others as part of the journey, the community. accepts you and grows with you. So it's it's really special and all that. So with the investment.
Speaker: but You're turning over the reins of the CEO role. ah'll Talk to us a little bit about this, but you're still going to be very active. And what does that look like? Yeah, so My...
Speaker: I would say my decision and my choice was really to find someone who could take over this role of being CEO, because for me, being CEO made sense as being also the main shareholder.
Speaker: With investors, it's clearly we want to do things differently. And I think... I have ah some skills to grow the business from zero to what it is now. But for next phase, it's good to have some experienced CEO who could scale the company, scale.
Speaker: everywhere and especially in the US and also work with investors who have also methodology and who are used to a method at all. a bit different from the way I drove the company. So I think it it was key for me to, with this investment, to move from this role of CEO and leave this to someone else. and we we have been able to select someone.
Speaker: together so Sage Montardien and myself who we consider being very, very good with the right experience, the right knowledge of the field and so on. So I'm very happy having her. ah Being CEO for now, a bit more than two weeks.
Speaker: and myself so The main difference is that I don't spend time taking decisions every, I would say, hour, but more focusing on the product, which was the... also part of my contribution as the founder so I'm going to keep this role and also in addition being part of the board with the people from Sage Montargéant as well as Oksana.
Speaker: Well, I certainly applaud you because over the history here, you make a decision. you know Do you want to grow? um Do you have that skill for the next phase? Because you know it's very clear that...
Speaker: There's a certain skill set and and the passion that comes from just starting a company. you know from from nothing you know kind of in the garage or in a in my case, in the spare room of the house with a folding table and a cell phone. And, you know, you grow to a certain point and there and there's that critical decision is...
Speaker: Do we continue to grow and... Is that something that I'm skilled or do I bring somebody else in that skill but still play a different role? so My hat's off to you because I'm sure those were difficult decisions. It must have been really interesting and fun. To find the right person, you know, for you and Endnova and all the customers to sit in the new.
Speaker: CEO chair. So that must have been very, very exciting to go through that process. I wouldn't say it has been a difficult. ah decision, because I mean, at some time,
Speaker: When I took the decision, it was the decision of the soul. And where we have been lucky is to be able to find someone, well, not in one year, but now where we think everyone thinks it's the right person. So I think we have been lucky.
Speaker: on that and that um No, I wouldn't say it's difficult. for so I know that some people who are founders find it difficult. I wouldn't say I do. which' I mean, it's normal evolution.
Speaker: All right. Well, that's excellent. That's even better news. So certainly these days, we can't have one of these conversations without AI. You know, that's kind of is his front and center.
Speaker: And it's interesting because there's a lot of automation that's going out there and automation happens all the time. Right. But some are calling that AI. Right. But then there's true AI and Gentech. It's really, really interesting.
Speaker: interesting time. So... So let's talk about that. You know, certainly you guys have really embraced it. It's really interesting what you're doing. But for our listeners. How are you thinking about it? What are you expecting both in the near term and also the longer term?
Speaker: is So maybe is maybe I can remind you. people i think we we talked about that like two years ago but
Speaker: For us, investing in AI is not something new. It's not something we decided last year when we realized that... Adjantic AI is a three tremendous change for everyone. So it's just something we started in 2018. I remember you were at a customer site in Switzerland at that time when we presented our Enob Labs department where we invested on and ah NLP, machine learning, and so on. And it's true that beginning of 2021 and so on, there has been Gen AI and then Adjantic AI, which is really well. The game changer, I would say.
Speaker: and and we have released in enough platform for now two years some features around ai and engine ai and then the key point now is that we released this month so on the platform a full agentic ai framework so this is
Speaker: part of the platform it means concretely for people who are used to use the anthropic tools or chat gpt exactly ah what you can do with cloud core for example So it is interacting with your own files and so on. or or any application you plug your co -work on, you can do this from within Enov, the latest version.
Speaker: You can do it with the data managed within Hinov, whether it's documents, whether it's data, whether it's processes. So all the data of our customers can be used with our Identity AI framework.
Speaker: just for not only for querying but also for interacting and creating and so on it's very powerful And the key thing when we decided to develop this is really to we recognize that the LLMs, it's something which are, I mean, there are new LLMs there.
Speaker: I would say months and they are even better. every month And so we rely on the elements that our customers use. but we have put in place the framework so that our customers can really get value from This framework, Authentic AI and LLM, and their data, because the key thing is having the right data up to date and really enough being considered a single source of truth. is a
Speaker: key thing to be able to bring value and to get value from. this repository of data using GNI and agentic AI tools. So this is what we have. right into the platform available now. So this is key. And we continue investing because obviously there will be more and more tools around this but we as you know you we release every six months a new version So 11 .2 in September is where we provide agentic AI.
Speaker: what is interesting in this is that in this framework. We support, of course, prompt bat skills agents. And... you know we have our technical platform And on top of that, we have core models. So we have core models for quality, regulatory and so on. And so the skills we deliver, we deliver the skills
Speaker: for regulatory of the skills for quality and it's part of a core model. So once you invest in our AI framework or AI component in the platform, you benefit from the skills that are delivered with a core model. So it's really something which is out of the box.
Speaker: and As always with our solution, it's configurable so we provide out -of -the -box skills but they can be updated and hence modified and so on by our customers so it's really something that can adapt to each of our customers but which is it can be used out of the box so this is something i think which is really important and probably a key differentiator with with our competitors there
Speaker: Yeah, and i I want to go a little deeper on that because I think we first got introduced maybe about 10 years ago. And it was with one of my colleagues, Chet, and you know he said, you've got to start.
Speaker: understanding end of they're the best kept secret in industry in the regulatory space and I think that's when we started to get to know each other and and learn from each other and My audience knows there's so many software providers.
Speaker: that we review. Some come and go over the years. Some are steady and strong over time, like yourselves. But ah a lot, especially in this AI era, we we get caught up on the AI.
Speaker: the agentic is a game changer it's incredible it's an incredible technology but We've been starting to. think and talk about fourth generation systems. But then it's like fourth generation systems. It isn't a system.
Speaker: It's the fourth generation data architecture. And one thing I've always appreciated. I think Endnov and one other company, even in the last 10 years, you know, and people use different terms and we're connected and.
Speaker: different modules, but you've always had a unified data model, regardless if it's clinical, regulatory, quality. type of thing. And I would imagine that unlike other.
Speaker: competitors that didn't have they might say they have it, but they don't have that unified data model. That must be a strategic advantage for you right now in in the AI era on that. So I don't know if you have any comments about it. It's just an observation from my chair.
Speaker: Yes, I think it is, because actually the question is the really… ah the The integrity, the consistency of the data. ah make sure it's the right data is the key thing because i mean if you are an ai or with data you're not sure ah you have three systems where you have to synchronize data between quality and regulatory for example and well It makes things... complicated. So this is from for me what we do.
Speaker: first Providing a platform where you manage all your documents, data and process processes in one single repository is the key thing to to make sure. you manage well your data and you have a single source of truth this is one thing the other thing is
Speaker: the way We try to be very pragmatic and we don't so we don't develop Sometimes with some specific use case, we train some LLMs to address specific needs like in ah signal detection or duplicate detection in pharmacology. But in general, what we do, we rely on the best LLMs that our customers use. but we open the system so um There is always this discussion whether for our customers customers, should they build or should they buy?
Speaker: Should they build from... entropic from OpenAI their own system or should they buy something from their current vendors? The two are possible, and and most of the time there is a mix of the two. But if you build something and you say, well, you have some data in different systems and you... build a a data lake and so on and you you plug on that a rag and then you plug your energetic ai framework
Speaker: well first it takes time and you duplicate the data and so on the the option what we propose so of course you can always do this within you can extract the data but you have a question of security and so on what we propose is really to be able to Plug your your MCP client, like let's say Cowork, and you plug it directly on an off -server, and you access directly the data with the security and so on. So you don't duplicate this information.
Speaker: you just access it, you interact with it, so you have an investigation on a deviation, you want to create an action plan, you have a proposal in your cloud co -work, and then we always provide human in the loop, of course, and then you decide to create the action plan, you create it, and it's created into a node under your name and so it's really the user who interacts with the data but you we Make it.
Speaker: easier faster um and with in a secure way so really we try to be pragmatic when deploying the solutions, not having to do a lot of integrations.
Speaker: ah So this is consistent with or also our philosophy, which is to... to have everything into a now so that there is no integration between quality regulatory and so on so this is the way we see this and the way why we implement Peace.
Speaker: mcp protocol whether client and servers of it we can interact with the data. off with it ah from enough as well as from external solution. Yeah. And there's beauty in simplicity. You listed like data lakes, all these different parts, you know, kind of. ah the The system of record, the system of action could be a daily AI layer, but there's nothing like, you know, simplicity. and Out of all the business cases we've helped clients with, and there's been a lot.
Speaker: And even in our research, it always comes down to the number one. part of a business case, is especially for larger companies, is how can we consolidate? How can we simplify?
Speaker: you know, how how can we improve the environment? So it's all about simplification and taking out waste. waste And then you have a lot of smaller companies too. Yes. And that's all about scale. Can I scale with this partner and add these different modules very quickly and not rethinking data models? It's just a... a really quick expansion. So it looks like you're accomplishing.
Speaker: both sides of the menu, if you will. Yes, exactly. And for example, with regulatory intelligence, so... It's a matter, I mean, the regulatory intelligence processes can be a bit complex. It's a matter of acquiring the data, acquiring well the data. ah It can be data that comes from external sources as well as the one managed within the company, as well as
Speaker: all submissions regulatory data that are managed within the system and so it means with with this as an extension of our data model we are able to Either, like...
Speaker: query the system to see what should be done and so on. But we we are able, it's not available yet, it's coming in the next version, we're able to propose ah what should be done on, the for example, the submission with a renewal deadline at some time and we used to propose what should be done and so on. So it means that... We can be proactive.
Speaker: using all these frameworks. As well as the data, we can be proactive to provide recommendations. okay so this is i think a key enhancement that all our customers are looking for Yeah, definitely exciting times. and Actually, one more question, and and hopefully it's a really fun question, especially with the transition going on.
Speaker: And I would imagine you have a vision and hope. um Where will EndNote be in the next ah few years? Because you're in a transition anyway. industry's in the transition too so it's really exciting time so So what does the crystal ball tell you, Olivier?
Speaker: I would say we we recognize that the nature of work is changing. for our customers and for all companies. and including enough, okay? And so what what we think and our value is really to evolve with with the different...
Speaker: processes of our customers that evolve. This is the flexibility of a platform. So we really ah make sure that we'll be able to bring value to our customers now in six months, in two years, because of a flexible data model where we can adapt our workflow. And globally, in a few years, I'm not going to speak in terms of revenue or whatever, because maybe you could invite our new CEO, we'd be happy to provide more details on that. But globally, we really want to become the platform of choice globally for innovative and and dynamic customers in the life science industry, of course, as well as healthcare, as well as adjacent industries. So this is really... ah becoming the platform of choice.
Speaker: And everywhere we are. in some countries but we want to do to be this platform of choice on in the US, in Europe globally, and also in Asia.
Speaker: Yes. So that's exciting. And one thing I can say, just knowing Endove and yourself, you know, over the past decade is. You're always innovating and you're always thinking ahead. You're always applying it.
Speaker: um So that's really exciting because... We started tracking the regulatory space as early as 2005. It's kind of hard to believe. and You know, there's companies that were very strong then. They kind of come and go. There's some newcomers, but there's very few companies.
Speaker: ah that stays strong over decades. So congratulations. and Thank you you know you. Exciting times with the next cell you know kind of next few years. So with that, maybe some of our listeners might want to reach out. So how do they get a hold of you?
Speaker: Oh. Same as before, I would say, no. I don't know, the same as before, i it could be a LinkedIn, it could be email, so no change.
Speaker: And certainly for our audience, same here. I'm very active on LinkedIn or you can go to the Gins and Associates. website and go on the contact page. so um Thanks again. Always enjoy the conversation. Best of luck with the transition. I know well and know you've innovated over the years and we're expecting ah you to continue to innovate for many more.
Speaker: Yes, we'll continue absolving, yes. So thank you for the invitation. And maybe we'll do another podcast recording in a few years. Absolutely. We look forward to it and enjoy it. Thanks so much.
Speaker: Thank you.


